• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Diarylethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Diarylethers

Professional Introduction to 4-[(5-formylpyridin-2-yl)oxy]benzonitrile (CAS No. 328547-41-7)

4-[(5-formylpyridin-2-yl)oxy]benzonitrile, identified by the Chemical Abstracts Service Number (CAS No.) 328547-41-7, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic aromatic nitrile exhibits a unique structural framework that has garnered considerable attention from researchers due to its potential applications in drug development and material science.

The molecular structure of 4-[(5-formylpyridin-2-yl)oxy]benzonitrile consists of a benzonitrile core substituted with an oxyphenyl group linked to a formyl-substituted pyridine ring. This configuration imparts distinct chemical properties, making it a versatile intermediate in the synthesis of more complex molecules. The presence of both formyl and nitrile functional groups allows for diverse chemical transformations, including condensation reactions, nucleophilic additions, and cyclization processes, which are pivotal in constructing biologically active scaffolds.

In recent years, the pharmaceutical industry has shown increasing interest in compounds featuring pyridine and benzene derivatives due to their well-documented pharmacological activities. Pyridine-based structures are frequently found in active pharmaceutical ingredients (APIs) due to their ability to interact with biological targets such as enzymes and receptors. The formyl group in 4-[(5-formylpyridin-2-yl)oxy]benzonitrile serves as a reactive handle, enabling further functionalization through reactions like Schiff base formation and aldehyde-ketone transformations.

One of the most compelling aspects of this compound is its utility in the synthesis of heterocyclic drugs. Heterocycles are integral to many modern medicines, including antiviral, anti-inflammatory, and anticancer agents. The benzonitrile moiety contributes to the electron-withdrawing nature of the molecule, which can influence its binding affinity and metabolic stability. Additionally, the pyridine ring provides a hydrogen bond donor/acceptor site, enhancing interactions with biological targets.

Recent studies have highlighted the role of 4-[(5-formylpyridin-2-yl)oxy]benzonitrile in developing novel therapeutic agents. For instance, researchers have explored its derivatives as potential inhibitors of kinases and other enzymes implicated in diseases such as cancer and neurodegeneration. The formyl group has been particularly useful in generating Schiff bases with metal ions, which exhibit catalytic activity in various biochemical pathways. These findings underscore the compound's significance as a building block for innovative drug discovery.

The synthesis of 4-[(5-formylpyridin-2-yl)oxy]benzonitrile typically involves multi-step organic reactions starting from commercially available precursors. A common synthetic route includes the formation of an ether linkage between a phenol derivative and a formylated pyridine via nucleophilic substitution or condensation reactions. Subsequent introduction of the nitrile group can be achieved through cyanation methods or reductive amination processes. These synthetic strategies highlight the compound's accessibility while maintaining high yields and purity standards suitable for pharmaceutical applications.

The chemical reactivity of this compound also makes it valuable in material science applications. For example, its ability to undergo cross-coupling reactions with aryl halides or boronic acids allows for the construction of more complex aromatic systems. These extended structures have potential uses in organic electronics, such as light-emitting diodes (LEDs) and photovoltaic cells, where precise molecular architecture is critical for optimal performance.

In conclusion, 4-[(5-formylpyridin-2-yl)oxy]benzonitrile (CAS No. 328547-41-7) represents a versatile intermediate with broad applications in pharmaceutical chemistry and material science. Its unique structural features enable diverse synthetic pathways leading to biologically active molecules and advanced materials. As research continues to uncover new therapeutic targets and technological needs, compounds like this will remain indispensable tools for scientists seeking innovative solutions.

• 888967-60-0(Benzonitrile, 3-[(5-formyl-2-pyridinyl)oxy]-)
• 866049-85-6(4-[(3-formylpyridin-2-yl)oxy]benzonitrile)
• 51362-38-0(6-Phenoxynictinic Acid)
• 173282-69-4(6-Phenoxynicotinaldehyde)
• 99902-71-3(6-(4-acetylphenoxy)pyridine-3-carbonitrile)
• 99902-75-7(6-(4-methylphenoxy)pyridine-3-carbonitrile)
• 870062-26-3(Benzonitrile, 3-[(5-methyl-2-pyridinyl)oxy]-)
• 99902-72-4(6-Phenoxynicotinonitrile)
• 676501-68-1(6-(4-formylphenoxy)pyridine-3-carbonitrile)
• 338960-65-9(6-(4-methylphenoxy)pyridine-3-carbaldehyde)